Following New York state guidance, MSK has suspended offering the J & J/Janssen vaccine. We continue to offer the Pfizer-BioNTech and Moderna vaccines to our eligible patients. Appointments can be scheduled here. For more on the J & J vaccine, read this.
As Chief of the Computer Service, I coordinate the activities of a team of medical physicists, programmer/analysts, and computer management staff in developing and supporting advanced computer applications that service the departments of Medical Physics, Radiation Oncology, and Radiology. A major focus of the team is the development of computer systems for external radiotherapy and brachytherapy.
My own research interests have focused on improving the accuracy of radiation therapy by developing new patient imaging and treatment techniques to locate tumors more precisely and to reduce the movement of internal organs during treatment.
Medical physicist Gikas Mageras focuses on radiation treatment planning and verification using CT images to guide radiation treatment and monitor and correct for patient internal and external movement during treatment delivery.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Gikas S. Mageras discloses the following relationships and financial interests:
Varian Medical Systems Intellectual Property Rights
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at firstname.lastname@example.org.